Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Qiagen, Applied Biosystems settle patent dispute

This article was originally published in Clinica

Executive Summary

Qiagen and Applied Biosystems have settled a patent dispute over real-time PCR detection technology, clearing all litigation between the two firms. Last year, Applied Biosystems filed a complaint in Germany against Corbett which alleged that the latter's Rotor-Gene real-time PCR cycler technology infringed patents that Applied Biosystems held for real-time thermal cycler instruments. Corbett responded by filing a separate suit against Applied Biosystems in California. In June 2008, Qiagen bought Corbett for $135m (see Clinica No 1313, p 3), thus assuming responsibility for Corbett’s lawsuit. As part of the resolution, Corbett has taken a license from Foster City, California-based Applied Biosystems, which will enable it to sell its Rotor-Gene for all fields, including molecular research and human and animal in vitro diagnostics purposes. Financial terms of the settlement were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041622

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel